|
HU212435B
(en)
|
1990-06-07 |
1996-06-28 |
Sandoz Ag |
Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
|
|
WO1995001961A1
(en)
|
1993-07-09 |
1995-01-19 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
JPH08295646A
(ja)
|
1995-04-26 |
1996-11-12 |
Teijin Ltd |
ビス（ヒドロキシエトキシフェニル）化合物の製造方法
|
|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
US6187774B1
(en)
|
1996-03-04 |
2001-02-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and pharmaceutical applications thereof
|
|
AU5907898A
(en)
|
1997-01-13 |
1998-08-03 |
Penn State Research Foundation, The |
Asymmetric synthesis and catalysis with chiral heterocyclic compounds
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
US6628343B1
(en)
|
1997-05-23 |
2003-09-30 |
Sony Corporation |
Television signal reception circuit, automatic phase shift control circuit and equal amplitude addition circuit
|
|
IT1292461B1
(it)
|
1997-07-03 |
1999-02-08 |
Great Lakes Chemical Italia |
Composti fotocromatici,procedimento per la loro preparazione e loro utilizzo in materiali polimerici
|
|
HUP0104634A3
(en)
|
1998-07-06 |
2002-11-28 |
Bristol Myers Squibb Co |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
EP1237547A2
(en)
|
1999-07-09 |
2002-09-11 |
Isis Innovation Limited |
Compounds for inhibiting diseases and preparing cells for transplantation
|
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
CA2416384A1
(en)
|
2000-07-17 |
2003-01-16 |
Takeda Chemical Industries, Ltd. |
Sulfone derivatives, their production and use
|
|
WO2002046164A1
(en)
|
2000-12-07 |
2002-06-13 |
Astrazeneca Ab |
Therapeutic compounds
|
|
BR0116468A
(pt)
|
2000-12-08 |
2004-06-29 |
Ortho Mcneil Pharm Inc |
Compostos de pirrolina substituìda por indazolila como inibidores de cinase
|
|
WO2003000682A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
US7192939B2
(en)
|
2002-01-30 |
2007-03-20 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
|
CN1642599A
(zh)
|
2002-02-27 |
2005-07-20 |
辉瑞产品公司 |
Acc抑制剂
|
|
KR20050043967A
(ko)
|
2002-09-17 |
2005-05-11 |
액테리온 파마슈티칼 리미티드 |
1-피리딘-4-일-요소 유도체
|
|
AU2003278600A1
(en)
|
2002-11-01 |
2004-05-25 |
Takeda Pharmaceutical Company Limited |
Agent for preventing or treating neuropathy
|
|
CA2505322A1
(en)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
US20070004736A1
(en)
|
2002-11-22 |
2007-01-04 |
Keiji Kubo |
Imidazole derivative, process for producing the same, and use
|
|
US20040259179A1
(en)
|
2003-05-30 |
2004-12-23 |
Gerd Assmann |
Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
|
EP1630152A4
(en)
|
2003-05-30 |
2009-09-23 |
Takeda Pharmaceutical |
CONDENSED CYCLIC COMPOUND
|
|
ES2319539T3
(es)
|
2003-09-17 |
2009-05-08 |
Janssen Pharmaceutica Nv |
Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
|
|
EP1669352A4
(en)
|
2003-09-30 |
2008-12-17 |
Takeda Pharmaceutical |
THIAZOLINE DERIVATIVE AND ITS USE
|
|
EP1695961A4
(en)
|
2003-12-17 |
2007-10-24 |
Takeda Pharmaceutical |
UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
|
|
ATE461217T1
(de)
|
2003-12-18 |
2010-04-15 |
Novo Nordisk As |
Glp-1-verbindungen
|
|
WO2005066136A1
(en)
|
2003-12-22 |
2005-07-21 |
Eli Lilly And Company |
Bicyclic derivatives as ppar modulators
|
|
AU2004309271A1
(en)
|
2003-12-25 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl)propanoic acid derivatives
|
|
WO2005063725A1
(ja)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
フェニルプロパン酸誘導体
|
|
JP4875978B2
(ja)
|
2004-03-15 |
2012-02-15 |
武田薬品工業株式会社 |
アミノフェニルプロパン酸誘導体
|
|
US7517910B2
(en)
|
2004-03-30 |
2009-04-14 |
Takeda Pharmaceutical Company Limited |
Alkoxyphenylpropanoic acid derivatives
|
|
WO2005112932A2
(en)
|
2004-05-07 |
2005-12-01 |
Exelixis, Inc. |
Raf modulators and methods of use
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
AP2006003768A0
(en)
|
2004-05-25 |
2006-10-31 |
Pfizer Prod Inc |
TetraazabenzoÄeÜazulene derivatives and analogs tehereof
|
|
WO2005121138A2
(en)
|
2004-06-03 |
2005-12-22 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as hcv inhibitors
|
|
US20050287100A1
(en)
|
2004-06-08 |
2005-12-29 |
Lebre Caroline |
Cosmetic composition comprising a semi-crystalline polymer and a dispersion of polymer in fatty phase
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
WO2006034419A2
(en)
|
2004-09-21 |
2006-03-30 |
Athersys, Inc. |
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
EP2298295B1
(en)
|
2005-01-31 |
2013-08-28 |
Cephalon, Inc. |
Tumor necrosis factor inhibitors
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
WO2007009883A1
(en)
|
2005-07-15 |
2007-01-25 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl fused cyclic amines
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
US20090054435A1
(en)
|
2005-07-29 |
2009-02-26 |
Hiroshi Imoto |
Phenoxyalkanoic Acid Compound
|
|
TW200740435A
(en)
|
2005-08-10 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Therapeutic agent for diabetes
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
JP4955009B2
(ja)
|
2005-11-11 |
2012-06-20 |
エフ．ホフマン−ラ ロシュ アーゲー |
凝固因子Ｘａの阻害剤としての炭素環式縮合環アミン
|
|
EP1986643A1
(en)
|
2006-02-10 |
2008-11-05 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
EP2010520B1
(en)
|
2006-04-20 |
2012-09-12 |
Pfizer Products Inc. |
Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
|
|
RS53230B
(sr)
|
2006-06-27 |
2014-08-29 |
Takeda Pharmaceutical Company Limited |
Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
EP2046333A4
(en)
|
2006-07-24 |
2010-09-15 |
Glaxosmithkline Llc |
THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
|
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
|
RU2454415C9
(ru)
|
2006-10-19 |
2013-02-27 |
Такеда Фармасьютикал Компани Лимитед |
Производное индола
|
|
EP2091921A2
(en)
|
2006-11-03 |
2009-08-26 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
|
BRPI0721053A2
(pt)
|
2006-11-29 |
2014-07-29 |
Pfizer Prod Inc |
INIBIDORES DE ESPIROCETONA ACETIL-CoA CARBOXILASE
|
|
US20130012485A1
(en)
|
2006-12-22 |
2013-01-10 |
Baeschlin Daniel Kaspar |
Organic compounds
|
|
EP2128138A1
(en)
|
2007-01-29 |
2009-12-02 |
Takeda Pharmaceutical Company Limited |
Pyrazole compound
|
|
JP2010517935A
(ja)
|
2007-02-09 |
2010-05-27 |
武田薬品工業株式会社 |
Ｐｐａｒ−ガンマのパーシャルアゴニストとしての縮合環化合物
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
JPWO2008136428A1
(ja)
|
2007-04-27 |
2010-07-29 |
武田薬品工業株式会社 |
含窒素５員複素環化合物
|
|
WO2008156757A1
(en)
|
2007-06-19 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Indazole compounds for activating glucokinase
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
WO2009036275A1
(en)
|
2007-09-13 |
2009-03-19 |
Link Medicine Corporation |
Treatment of neurodegenerative diseases using indatraline analogs
|
|
WO2009099736A2
(en)
|
2008-02-06 |
2009-08-13 |
Lead Therapeutics, Inc. |
Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp)
|
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
WO2009144555A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
CN102105159B
(zh)
|
2008-06-17 |
2015-07-08 |
印第安纳大学研究及科技有限公司 |
基于gip的混合激动剂用于治疗代谢紊乱和肥胖症
|
|
JP2011529483A
(ja)
|
2008-07-29 |
2011-12-08 |
ファイザー・インク |
フッ素化ヘテロアリール
|
|
AU2009286380B2
(en)
|
2008-08-28 |
2011-09-15 |
Pfizer Inc. |
Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
|
|
US8735391B2
(en)
|
2008-09-26 |
2014-05-27 |
University Of Kansas |
Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
AR075051A1
(es)
|
2009-02-05 |
2011-03-02 |
Schering Corp |
Compuestos antidiabeticos que contienen ftalazina
|
|
CA2754685A1
(en)
|
2009-03-11 |
2010-09-16 |
Pfizer Inc. |
Substituted indazole amides
|
|
EP2604604A1
(en)
|
2009-03-11 |
2013-06-19 |
Pfizer Inc |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
CA2759843A1
(en)
|
2009-05-08 |
2010-11-10 |
Pfizer Inc. |
Gpr 119 modulators
|
|
US20120052130A1
(en)
|
2009-05-08 |
2012-03-01 |
Pfizer Inc. |
Gpr 119 modulators
|
|
NZ596467A
(en)
|
2009-06-05 |
2014-01-31 |
Pfizer |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
|
JP5805982B2
(ja)
|
2011-04-20 |
2015-11-10 |
ユニチカ株式会社 |
ポリアリレート樹脂フィルムおよび気体分離膜
|
|
JP5687120B2
(ja)
|
2011-04-20 |
2015-03-18 |
ユニチカ株式会社 |
ポリアリレート樹脂
|
|
JP6126097B2
(ja)
|
2011-09-06 |
2017-05-10 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１誘導体
|
|
KR101401705B1
(ko)
|
2012-01-31 |
2014-06-27 |
울산대학교 산학협력단 |
로듐 촉매를 이용한 이소인돌린 유도체의 합성방법
|
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
|
US20150272939A1
(en)
|
2012-10-02 |
2015-10-01 |
Yale University |
Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase
|
|
WO2014101120A1
(en)
|
2012-12-28 |
2014-07-03 |
Merck Sharp & Dohme Corp. |
Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
|
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
|
CN109867630A
(zh)
|
2013-06-11 |
2019-06-11 |
赛尔基因第二国际有限公司 |
新型glp-1受体调节剂
|
|
CN103421006B
(zh)
|
2013-08-18 |
2016-06-22 |
上海师范大学 |
2,3,5,7-四取代二氢吡唑并六氢吡啶衍生物及其制备方法和应用
|
|
EP2857550A1
(en)
|
2013-10-02 |
2015-04-08 |
Basf Se |
Amine precursors for depositing graphene
|
|
CA2955836C
(en)
|
2014-07-25 |
2023-02-14 |
Celgene International Ii Sarl |
Glp-1 receptor modulators
|
|
EP2993174A1
(en)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
CN105646459A
(zh)
|
2014-11-13 |
2016-06-08 |
上海和辉光电有限公司 |
一种化合物及其制备方法和应用
|
|
WO2016118639A1
(en)
|
2015-01-20 |
2016-07-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule oxidizers of pdi and their use
|
|
SG11201805586SA
(en)
|
2015-12-31 |
2018-07-30 |
Hanmi Pharmaceutical Co Ltd |
Triple glucagon/glp-1/gip receptor agonist
|
|
WO2017182984A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis (4-hydroxyaryl) phthalimidines, and polymers derived therefrom
|
|
WO2017182986A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182983A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
JOP20190060A1
(ar)
*
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
KR102314286B1
(ko)
*
|
2016-12-16 |
2021-10-21 |
화이자 인코포레이티드 |
Glp-1 수용체 작용제 및 이의 용도
|
|
EP3600270B1
(en)
|
2017-03-31 |
2023-06-14 |
Aurigene Oncology Limited |
Compounds and compositions for treating hematological disorders
|
|
TWI782056B
(zh)
|
2017-07-14 |
2022-11-01 |
日商鹽野義製藥股份有限公司 |
具有ｍｇａｔ２抑制活性的縮合環衍生物
|
|
JP7461104B2
(ja)
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
WO2019126424A1
(en)
|
2017-12-22 |
2019-06-27 |
Chemocentryx, Inc. |
DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS
|
|
AR114237A1
(es)
|
2018-02-01 |
2020-08-05 |
Japan Tobacco Inc |
Compuesto de amida heterocíclica que contiene nitrógeno y su uso farmacéutico
|
|
MX2020008265A
(es)
|
2018-02-16 |
2020-09-21 |
UCB Biopharma SRL |
Derivados farmaceuticos del anillo heterobiciclico 6,5.
|
|
EP3759110A1
(en)
|
2018-02-28 |
2021-01-06 |
Novartis AG |
Indole-2-carbonyl compounds and their use for the treatment of hepatitis b
|
|
US20190284341A1
(en)
|
2018-03-14 |
2019-09-19 |
Sabic Global Technologies B.V. |
3-oxo-2-alkylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
US20190284340A1
(en)
|
2018-03-14 |
2019-09-19 |
SABIC Global Technologies B.V |
3-oxo-2-arylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
BR112020019822A2
(pt)
|
2018-04-02 |
2021-03-16 |
Chemocentryx, Inc. |
Profármacos de antagonistas bicíclicos fundidos de c5ar
|
|
US10934279B2
(en)
|
2018-06-13 |
2021-03-02 |
Pfizer Inc. |
GLP-1 receptor agonists and uses thereof
|
|
DK3806855T5
(da)
*
|
2018-06-15 |
2023-05-22 |
Pfizer |
GLP-1-receptoragonister og anvendelser deraf
|
|
WO2020001321A1
(en)
|
2018-06-27 |
2020-01-02 |
The Hong Kong Polytechnic University |
Compounds with antimicrobial activity
|
|
US11923622B2
(en)
|
2018-08-02 |
2024-03-05 |
Nokia Solutions And Networks Oy |
Antenna and wireless communication device
|
|
US11254660B2
(en)
|
2018-08-31 |
2022-02-22 |
Pfizer Inc. |
Combinations for treatment of NASH/NAFLD and related diseases
|
|
AR117189A1
(es)
|
2018-11-02 |
2021-07-21 |
Aicuris Gmbh & Co Kg |
Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb)
|
|
PY1991603A
(es)
|
2018-11-02 |
2020-09-17 |
Aicuris Gmbh & Co Kg |
Nueva 6,7-dihidro-4h-pirazolo [1,5-a] pirazina indole -2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
MA54555A
(fr)
|
2018-11-22 |
2021-09-29 |
Qilu Regor Therapeutics Inc |
Agonistes de glp-1r et leurs utilisations
|
|
CN111217842B
(zh)
|
2018-11-26 |
2023-01-31 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用
|
|
CN111217796B
(zh)
|
2018-11-26 |
2021-12-14 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷/二吡咯甲川化合物及其制备方法和应用
|
|
CN113365637A
(zh)
|
2018-12-05 |
2021-09-07 |
维京治疗公司 |
用于治疗肝部病症的组合物和方法
|
|
US20220204473A1
(en)
|
2018-12-25 |
2022-06-30 |
Shanghai Meiyue Biotech Development Co., Ltd. |
Compound as irak inhibitor
|
|
WO2020163236A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Treating long qt syndrome
|
|
EP3953344A4
(en)
|
2019-04-12 |
2023-08-09 |
Qilu Regor Therapeutics Inc. |
GLP-IR AGONISTS AND THEIR USES
|
|
WO2020234726A1
(en)
|
2019-05-20 |
2020-11-26 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CN110804059B
(zh)
|
2019-09-30 |
2024-03-12 |
郑州泰基鸿诺医药股份有限公司 |
氨基甲酸酯类化合物、药物组合物及其应用
|
|
EP4048664A1
(en)
|
2019-10-25 |
2022-08-31 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2021096284A1
(ko)
|
2019-11-15 |
2021-05-20 |
일동제약(주) |
Glp-1 수용체 작용제 및 이의 용도
|
|
HRP20241159T1
(hr)
|
2020-02-07 |
2024-12-06 |
Gasherbrum Bio, Inc. |
Heterociklički agonisti za glp-1
|
|
JP7836762B2
(ja)
|
2020-02-13 |
2026-03-27 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
TW202206429A
(zh)
|
2020-04-29 |
2022-02-16 |
美商迦舒布魯姆生物有限公司 |
雜環ｇｌｐ—１促效劑
|